Catalyst Wire Dossier Catalyst Wire Dossier

Alginos Oral Suspension

· TTY Biopharm
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alginos Oral Suspension, covering 2015-06-08 to 2015-06-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Alginos Oral Suspension to Treat Laryngopharyngeal Reflux [Phase 3]

See pricing